John Gnann to Herpes Zoster Vaccine
This is a "connection" page, showing publications John Gnann has written about Herpes Zoster Vaccine.
Connection Strength
0.724
-
Vaccination to prevent herpes zoster in older adults. J Pain. 2008 Jan; 9(1 Suppl 1):S31-6.
Score: 0.304
-
Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine. J Infect Dis. 2013 Nov 01; 208(9):1386-90.
Score: 0.112
-
Safety of zoster vaccine in elderly adults following documented herpes zoster. J Infect Dis. 2013 Aug 15; 208(4):559-63.
Score: 0.110
-
Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis. 2012 Apr; 54(7):922-8.
Score: 0.101
-
The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis. 2008 Mar 01; 197 Suppl 2:S207-15.
Score: 0.077
-
Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain. 2008 Jan; 9(1 Suppl 1):S37-44.
Score: 0.019